BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27159533)

  • 1. Morphologists overestimate the nuclear-to-cytoplasmic ratio.
    Zhang ML; Guo AX; VandenBussche CJ
    Cancer Cytopathol; 2016 Sep; 124(9):669-77. PubMed ID: 27159533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young investigator challenge: The accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists.
    Vaickus LJ; Tambouret RH
    Cancer Cytopathol; 2015 Sep; 123(9):524-30. PubMed ID: 26375883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
    Hang JF; Charu V; Zhang ML; VandenBussche CJ
    Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the Paris system for reporting urine cytology to challenging cytology cases.
    Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
    Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and Reproducibility of Nuclear/Cytoplasmic Ratio Assessments in Urinary Cytology Specimens.
    Layfield LJ; Esebua M; Frazier SR; Hammer RD; Bivin WW; Nguyen V; Ersoy I; Schmidt RL
    Diagn Cytopathol; 2017 Feb; 45(2):107-112. PubMed ID: 28110502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Paris: an international survey in preparation for The Paris System for Reporting Urinary Cytology 2.0 (TPS 2.0).
    Kurtycz DFI; Wojcik EM; Rosenthal DL
    J Am Soc Cytopathol; 2023; 12(1):66-74. PubMed ID: 36274039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology.
    Barkan GA; Wojcik EM; Nayar R; Savic-Prince S; Quek ML; Kurtycz DF; Rosenthal DL
    Acta Cytol; 2016; 60(3):185-97. PubMed ID: 27318895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology.
    Barkan GA; Wojcik EM; Nayar R; Savic-Prince S; Quek ML; Kurtycz DF; Rosenthal DL
    Adv Anat Pathol; 2016 Jul; 23(4):193-201. PubMed ID: 27233050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Agreement for High-Grade Urothelial Cell Carcinoma in Atypical Urine Cytology: A Nationwide Survey Reveals a Tendency for Overestimation in Specimens with an N/C Ratio Approaching 0.5.
    Wang YH; Hang JF; Wen CH; Liao KC; Lee WY; Lai CR
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
    Straccia P; Bizzarro T; Fadda G; Pierconti F
    Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Characteristics of Urinary Tract Cytology: Observations From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.
    Barkan GA; Laucirica R; Auger M; Khalbuss W; Padmanabhan V; Souers R; Moriarty AT
    Arch Pathol Lab Med; 2015 Aug; 139(8):1009-13. PubMed ID: 26230653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.
    Sauter JL; Chen Y; Alex D; Balassanian R; Cuda J; Flanagan MB; Griffith CC; Illei P; Johnson DN; McGrath CM; Randolph ML; Reynolds JP; Spiczka AJ; van Zante A; VanderLaan PA;
    J Am Soc Cytopathol; 2020; 9(6):570-578. PubMed ID: 32861593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of medical training in cytopathology carried out by the journal Cytopathology.
    Anshu ; Herbert A; Cochand-Priollet B; Cross P; Desai M; Dina R; Duskova J; Evered A; Farnsworth A; Gray W; Gupta SS; Kapila K; Kardum-Skelin I; Kloboves-Prevodnik V; Kobayashi TK; Koutselini H; Olszewski W; Onal B; Pitman MB; Marinsek Z; Sauer T; Schenck U; Schmitt F; Shabalova I; Smith JH; Tani E; Vass L; Vielh P; Wiener H
    Cytopathology; 2010 Jun; 21(3):147-56. PubMed ID: 20482722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology of spontaneous nipple discharge--is it worth it? Performance of nipple discharge preparations in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.
    Moriarty AT; Schwartz MR; Laucirica R; Booth CN; Auger M; Thomas NE; Souers RJ
    Arch Pathol Lab Med; 2013 Aug; 137(8):1039-42. PubMed ID: 23899058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from quantitation.
    Alons CL; Veldhuizen RW; Boon ME
    Anal Quant Cytol; 1981 Sep; 3(3):178-81. PubMed ID: 7294537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paris Interobserver Reproducibility Study (PIRST).
    Kurtycz DFI; Barkan GA; Pavelec DM; Rosenthal DL; Wojcik EM; VandenBussche CJ; Mangiulli K; Olson MT
    J Am Soc Cytopathol; 2018; 7(4):174-184. PubMed ID: 31043274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
    Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
    Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.